(Q44769788)

English

Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis

scientific article published on 21 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis (English)

1 reference

Europe PubMed Central

6 December 2017

0 references

Jason Kindrachuk

4

object named as

Jason Kindrachuk

0 references

Scott A Halperin

7

object named as

Scott A Halperin

1 reference

Europe PubMed Central

6 December 2017

Robert E. W. Hancock

6

object named as

Robert E W Hancock

1 reference

Europe PubMed Central

6 December 2017

10

object named as

Volker Gerdts

1 reference

Europe PubMed Central

6 December 2017

9

object named as

Lorne A Babiuk

1 reference

Europe PubMed Central

6 December 2017

5

object named as

George K Mutwiri

1 reference

Europe PubMed Central

6 December 2017

Srinivas Garlapati

1

object named as

Srinivas Garlapati

1 reference

Europe PubMed Central

6 December 2017

author name string

Nelson F Eng

2

1 reference

Europe PubMed Central

6 December 2017

Tadele G Kiros

3

1 reference

Europe PubMed Central

6 December 2017

Jason Kindrachuk

4

1 reference

Europe PubMed Central

6 December 2017

Andrew A Potter

8

1 reference

Europe PubMed Central

6 December 2017

language of work or name

0 references

publication date

21 July 2011

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

29

1 reference

Europe PubMed Central

6 December 2017

38

1 reference

Europe PubMed Central

6 December 2017

6540-6548

1 reference

Europe PubMed Central

6 December 2017

CpG DNA as a vaccine adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Translating innate immunity into immunological memory: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Immunomodulatory activities of small host defense peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

CpG oligodeoxynucleotide synergizes innate defense regulator peptide for enhancing the systemic and mucosal immune responses to pseudorabies attenuated virus vaccine in piglets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Synthetic innate defence regulator peptide enhances in vivo immunostimulatory effects of CpG-ODN in newborn piglets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Non-specific effects of diphtheria tetanus pertussis vaccination on child mortality in Cebu, The Philippines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Pathogen recognition and development of particulate vaccines: does size matter?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Toll-like receptor 9-stimulated monocyte chemoattractant protein-1 is mediated via JNK-cytosolic phospholipase A2-ROS signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Induction, function and regulation of IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Immunoglobulin A-mediated protection against Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

In search of the elusive mouse macrophage Fc-alpha receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

based on heuristic

inferred from DOI database lookup

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.07.009

1 reference

Europe PubMed Central

6 December 2017

release_blwgy2vwd5hyxeikmgackqf5pe

1 reference

https://api.fatcat.wiki/v0/release/blwgy2vwd5hyxeikmgackqf5pe

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44769788&oldid=2040237297"